0001209191-16-122506.txt : 20160523 0001209191-16-122506.hdr.sgml : 20160523 20160523150600 ACCESSION NUMBER: 0001209191-16-122506 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160519 FILED AS OF DATE: 20160523 DATE AS OF CHANGE: 20160523 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jensen Peder CENTRAL INDEX KEY: 0001518724 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 161668775 MAIL ADDRESS: STREET 1: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-05-19 0 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001518724 Jensen Peder TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (right to buy) 42.25 2016-05-19 4 A 0 10000 0.00 A 2026-05-19 Common Stock 10000 0 D This option will vest in its entirety on the earlier to occur of (i) May 19, 2017 or (ii) the day before the 2017 annual meeting of stockholders of Five Prime Therapeutics, Inc. /s/ Francis Sarena, Attorney-in-fact 2016-05-23